2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow RVT-1401: new trials by email Literature Review of RVT-1401 trials Research Report on RVT-1401
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of RVT-1401 in Myasthenia Gravis (MG) Patients RVT-1401, Placebo - Myasthenia Gravis | Phase 2 | Completed | Immunovant Sciences GmbH | 17 | 2019-05-21 | 2023-12-20 |
| Study of RVT-1401 for the Treatment of Patients With Moderate to Severe Active Graves' Ophthalmopathy (GO) RVT-1401 - Graves' Ophthalmopathy | Phase 2 | Completed | Immunovant Sciences GmbH | 7 | 2019-04-22 | 2022-01-24 |
Graves Ophthalmopathy (1) · Myasthenia Gravis (1)
Canada (2) · United States (1)